Summit Investment Advisory Services’s Boston Scientific BSX Stock Holding History

Summit Investment Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,532	Closed	-$241K	–	82
2025 Q4	$241K	Hold	2,532	–	–	0.09%	73
2025 Q3	$247K	Hold	2,532	–	–	0.1%	67
2025 Q2	$272K	Sell	2,532 -56	-2%	-$5.67K	0.12%	54
2025 Q1	$261K	Buy	2,588 +56	+2%	+$5.64K	0.13%	57
2024 Q4	$226K	Hold	2,532	–	–	0.12%	66
2024 Q3	$212K	Buy	+2,532	New	+$200K	0.11%	63

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Summit Investment Advisory Services's BSX Position: Q1 2026 in Review

Summit Investment Advisory Services sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,532 shares — an estimated $241K sold.

Summit Investment Advisory Services first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $272K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Summit Investment Advisory Services reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Summit Investment Advisory Services sold 2,532 Boston Scientific shares in Q1 2026, an estimated $241K.
Summit Investment Advisory Services first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
Summit Investment Advisory Services's Boston Scientific position peaked at $272K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Summit Investment Advisory Services's 13F filing for Q1 2026, filed 23 Apr 2026.